DK103284A - Quinolincarboxylsyrer eller salte eller hydrater deraf, deres fremstilling og anvendelse som antibakterielle midler - Google Patents

Quinolincarboxylsyrer eller salte eller hydrater deraf, deres fremstilling og anvendelse som antibakterielle midler Download PDF

Info

Publication number
DK103284A
DK103284A DK103284A DK103284A DK103284A DK 103284 A DK103284 A DK 103284A DK 103284 A DK103284 A DK 103284A DK 103284 A DK103284 A DK 103284A DK 103284 A DK103284 A DK 103284A
Authority
DK
Denmark
Prior art keywords
antibacterials
hydrates
salts
preparation
quinolincarboxylic
Prior art date
Application number
DK103284A
Other languages
Danish (da)
English (en)
Other versions
DK103284D0 (da
Inventor
Uwe Petersen
Klaus Grohe
Hans-Joachim Zeiler
Karl Georg Metzger
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK103284D0 publication Critical patent/DK103284D0/da
Publication of DK103284A publication Critical patent/DK103284A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK103284A 1983-02-25 1984-02-24 Quinolincarboxylsyrer eller salte eller hydrater deraf, deres fremstilling og anvendelse som antibakterielle midler DK103284A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833306772 DE3306772A1 (de) 1983-02-25 1983-02-25 Chinolonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel

Publications (2)

Publication Number Publication Date
DK103284D0 DK103284D0 (da) 1984-02-24
DK103284A true DK103284A (da) 1984-08-26

Family

ID=6191897

Family Applications (1)

Application Number Title Priority Date Filing Date
DK103284A DK103284A (da) 1983-02-25 1984-02-24 Quinolincarboxylsyrer eller salte eller hydrater deraf, deres fremstilling og anvendelse som antibakterielle midler

Country Status (21)

Country Link
US (1) US4559342A (el)
EP (1) EP0117474B1 (el)
JP (1) JPS59157068A (el)
KR (1) KR870000891B1 (el)
AR (1) AR244669A1 (el)
AT (1) ATE23152T1 (el)
AU (1) AU562184B2 (el)
CA (1) CA1216849A (el)
DE (2) DE3306772A1 (el)
DK (1) DK103284A (el)
ES (1) ES8500931A1 (el)
FI (1) FI83955C (el)
GR (1) GR79988B (el)
HU (1) HU192398B (el)
IE (1) IE56924B1 (el)
IL (1) IL71036A (el)
NO (1) NO840557L (el)
NZ (1) NZ207238A (el)
PH (3) PH21906A (el)
PT (1) PT78114B (el)
ZA (1) ZA841375B (el)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3306772A1 (de) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen Chinolonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3306771A1 (de) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen Chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3308908A1 (de) * 1983-03-12 1984-09-13 Bayer Ag, 5090 Leverkusen Bakterizide mittel
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3420798A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-(3-aryl-l-piperazinyl)- sowie 7-(3-cyclohexyl-l-piperazinyl)-3-chinoloncarbonsaeuren
DE3504643A1 (de) * 1985-02-12 1986-08-14 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-1,4-dihydro-4-oxo-7-(4-(2-oxo-1,3-dioxol-4-yl-methyl)-1-piperazinyl)-3-chinolin carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
IT1200470B (it) * 1985-05-10 1989-01-18 Schering Spa Composti ad attivita' antibatterica,loro preparazione e composizioni farmaceutiche relative
ATE72668T1 (de) * 1985-09-24 1992-03-15 Hoffmann La Roche Chinolinderivate.
EP0224121A3 (en) * 1985-11-19 1987-11-11 ROTTAPHARM S.p.A. 7-[4-amino-piperazinyl]- or 7-[4-chloro-piperazinyl]quinolinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
DE3542002A1 (de) * 1985-11-28 1987-06-04 Bayer Ag 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
JPH0811749B2 (ja) * 1986-03-06 1996-02-07 富山化学工業株式会社 新規なキノリン誘導体およびその塩
DE3902079A1 (de) * 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
EP0338372A3 (en) * 1988-04-22 1991-10-09 American Cyanamid Company Solubilized pro-drugs
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
JPH04502317A (ja) * 1988-12-06 1992-04-23 ジ・アップジョン・カンパニー 抗菌性キノロン化合物
AU2003285963A1 (en) * 2002-11-11 2004-06-03 Austria Wirtschaftsservice Gesellschaft M.B.H. Fluorquinolines labelled with fluorine-18
EP2712911A3 (en) 2009-06-04 2014-08-06 JX Nippon Oil & Energy Corporation Lubricant oil composition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149104A (en) * 1961-01-03 1964-09-15 Sterling Drug Inc 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters
US3590036A (en) * 1968-11-18 1971-06-29 George Y Lesher Naphthyridine-3-carboxylic acids,their derivatives and preparation thereof
US4017622A (en) * 1972-12-18 1977-04-12 Dainippon Pharmaceutical Co., Ltd. Piperazine derivatives
SE444566B (sv) * 1977-09-20 1986-04-21 Bellon Labor Sa Roger 7-dialkylamin-6-halogen-4-oxo-1,4-dihydrokinolin-3-karboxylsyra, forfarande for framstellning derav och farmaceutiskt preparat derav
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
JPS5845426B2 (ja) * 1978-09-29 1983-10-08 杏林製薬株式会社 置換キノリンカルボン酸誘導体
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
EP0090424B1 (en) * 1982-03-31 1986-05-28 Sterling Drug Inc. New quinolone compounds and preparation thereof
DE3248505A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(4- (oxoalkyl)-1-piperazinyl/-3-chinolincarbonsaeuren und ihre derivate, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3306771A1 (de) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen Chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3306772A1 (de) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen Chinolonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel

Also Published As

Publication number Publication date
EP0117474B1 (de) 1986-10-29
ES530045A0 (es) 1984-11-01
CA1216849A (en) 1987-01-20
KR870000891B1 (ko) 1987-05-02
US4559342A (en) 1985-12-17
FI83955B (fi) 1991-06-14
AU2428384A (en) 1984-08-30
IL71036A0 (en) 1984-05-31
HU192398B (en) 1987-06-29
ES8500931A1 (es) 1984-11-01
PH22443A (en) 1988-09-12
NO840557L (no) 1984-08-27
IE840443L (en) 1984-08-25
KR840008013A (ko) 1984-12-12
FI840747A (fi) 1984-08-26
IE56924B1 (en) 1992-01-29
ZA841375B (en) 1984-10-31
FI83955C (fi) 1991-09-25
DE3306772A1 (de) 1984-08-30
PH21906A (en) 1988-04-08
PT78114A (en) 1984-03-01
EP0117474A1 (de) 1984-09-05
IL71036A (en) 1987-12-31
AU562184B2 (en) 1987-06-04
ATE23152T1 (de) 1986-11-15
PT78114B (en) 1986-04-30
JPH0430391B2 (el) 1992-05-21
DK103284D0 (da) 1984-02-24
GR79988B (el) 1984-10-31
AR244669A1 (es) 1993-11-30
FI840747A0 (fi) 1984-02-23
DE3461087D1 (en) 1986-12-04
JPS59157068A (ja) 1984-09-06
NZ207238A (en) 1986-05-09
PH23079A (en) 1989-04-10

Similar Documents

Publication Publication Date Title
DK103284D0 (da) Quinolincarboxylsyrer eller salte eller hydrater deraf, deres fremstilling og anvendelse som antibakterielle midler
DK58184D0 (da) 3-amino-1-benzazepin-2-on-1-alkansyrer og salte deraf samt deres fremstilling og anvendelse
DK562084D0 (da) Krystallinske galloaluminosilicater, dampmodificerede krystallinske galloaluminosilicater, deres fremstilling og anvendelse som katalysatorer og katalysatorunderlag
DK298984A (da) Tetrahydropyridazinoner eller syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler samt mellemprodukter og disses fremstilling
DK501384D0 (da) N-acyl-glycopeptidantibiotika eller salte deraf, deres fremstillingog anvendelse som antibiotika og foderudnyttelses- og maelkeproduktionsforbedrende midler
DK358784D0 (da) Phenylquinolincarboxylsyrer, derivater og salte deraf, deres fremstilling og anvendelse i antitumormidler
DK26784A (da) Aminosyrederivater, deres fremstilling og anvendelse
DK521986D0 (da) Benzylaminderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse som fungicider
DK448684D0 (da) Alkyldiaminderivater og deres anvendelse som laegemidler
DK298684A (da) (3-alkyl-5-isothiazolyl)-urinstoffer eller syreadditionssalte deraf, deres fremstilling og anvendelse som algicider og herbicider
NO842938L (no) Antracycylinderivater, fremgangsmaate til deres fremstilling og deres anvendelse som cytostatika
DK401482A (da) Alkylsulfoner, deres fremstilling og anvendelse
DK154586D0 (da) Alkanoylanilider eller salte deraf, deres fremstilling og anvendelse som insekticider og arachmicider
DK125583D0 (da) Benzensulfonylurinstoffer eller salte deraf, deres fremstilling og anvendelse
DK87682A (da) Aminoacridin-alfa,beta-(d)- eller -(l)-n-glycosid-derivater eller salte deraf,deres fremstilling og anvendelse som antisvulstmidler
DK317184A (da) 2-azabicyclo(2,2,2)octanderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika
DK256484D0 (da) Aryloxycycloalkanolaminoalkylenarylketoner eller salte deraf,deres fremstilling og mellemprodukter hertil
DK197083D0 (da) Cycloalkanderivater eller salte deraf, deres fremstilling og anvendelse som foderadditiver til forbedret vaegtforoegelse og foderudnyttelse
DK70484A (da) N-sulfenylerede hydantoiner, deres fremstilling og anvendelse som mikrobiocider
DK196983D0 (da) Carbazinsyrederivater eller salte deraf, deres fremstilling og anvendelse som foderadditiver til forbedret vaegtforoegelse og foderudnyttelse
DK555486A (da) Cephalosporiner eller salte deraf, deres fremstilling og anvendelse som laegemidler
DK298884A (da) (3-aryl-5-isothiazolyl)-urinstoffer eller syreadditionssalte deraf, deres fremstilling og anvendelse som algicider og herbicider
DK501484A (da) Glycopeptidantibiotikum eller salte deraf, deres fremstilling og anvendelse som antibiotika og foderudnyttelses- og maelkeproduktionsforbedrende midler
DK501184D0 (da) Glycopeptidantibiotikum eller salte deraf, deres fremstilling og anvendelse som antibiotika og foderudnyttelses- og maelkeproduktionsforbedrende midler
DK494282A (da) Cycliske iminderivater eller salte deraf, deres fremstilling og anvendelse som antiarytmiske midler

Legal Events

Date Code Title Description
ARF Application refused